Delivery Order SPE2DB20D2001-SPE2DB25FPMXA

Award Date 6/9/25
Potential Completion Date 6/10/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $2,291.66 and a period of performance through March 3, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product. The contract is a firm fixed-price delivery order with a ceiling value of $1,487.09 and a performance period through June 9, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,906.45. The contract is a firm fixed price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the procurement of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical supplies. The contract has a ceiling value of $29,008.50 and is a firm fixed price delivery order with a period of performance through March 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $11,577.35 and a performance period ending on May 20, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML pharmaceutical products, with a ceiling value of $1,007.62 and a performance period through June 11, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. Amerisourcebergen Drug...
This is a Delivery Order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products, with a ceiling value of $5,112.59 and a period of performance through February 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product, with a ceiling value of $9,009.89 and a performance period ending on June 4, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $2,008.11 and a period of performance through May 27, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides comprehensive pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $13,611.78 and a period of performance through April 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical,...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB25FPMXA
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a pharmaceutical product, ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $1,965.66 and a period of performance extending through June 10, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and has a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract positions Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 9/8/25, 9:54 AM